Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Gow

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Journal of Clinical Medicine|December 10, 2021
Epidemiology and Prognostic Significance of Rapid Response System Activation in Patients Undergoing Liver TransplantationMarcus Robertson, Andy K H Lim, Ashley Bloom, et al.
Transplantation|April 2, 2020
Inducible Left Ventricular Outflow Tract Obstruction in Patients Undergoing Liver Transplantation: Prevalence, Predictors, and Association With Cardiovascular EventsBenjamin Cailes, Anoop N Koshy, Paul Gow, et al.
Journal of Gastrointestinal Cancer|September 9, 2020
SIRT Compared with DEB-TACE for Hepatocellular Carcinoma: a Real-world Study (the SITAR Study)Ryan D Hirsch, Chris Mills, Rohit Sawhney, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2019
Retreatment with elbasvir, grazoprevir, sofosbuvir ± ribavirin is effective for GT3 and GT1/4/6 HCV infection after relapseTimothy Papaluca, Marie Sinclair, Paul Gow, et al.
International Journal of Epidemiology|October 16, 2003
Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001Matthew G Law, Gregory J Dore, Nicky Bath, et al.
World Journal of Transplantation|September 19, 2024
Statin, aspirin and metformin use and risk of hepatocellular carcinoma related outcomes following liver transplantation: A retrospective studyWilliam Chung, Kevin Wong, Noel Ravindranayagam, et al.
Science Advances|April 22, 2022
High coherence and low cross-talk in a tileable 3D integrated superconducting circuit architecturePeter A Spring, Shuxiang Cao, Takahiro Tsunoda, et al.
The Lancet. Gastroenterology & Hepatology|December 17, 2022
Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort studyManuel Luis Rodríguez-Perálvarez, Antonio Manuel Gómez-Orellana, Avik Majumdar, et al.
Scandinavian Journal of Gastroenterology|October 19, 2020
Efficacy and safety profile of calcineurin inhibitor salvage therapy in autoimmune hepatitisStuart K Roberts, Simone I Strasser, Amanda J Nicoll, et al.
Scandinavian Journal of Gastroenterology|November 6, 2018
Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survivalStuart K Roberts, Alessia Gazzola, John Lubel, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Journal of Clinical Medicine|December 10, 2021
Epidemiology and Prognostic Significance of Rapid Response System Activation in Patients Undergoing Liver TransplantationMarcus Robertson, Andy K H Lim, Ashley Bloom, et al.
Transplantation|April 2, 2020
Inducible Left Ventricular Outflow Tract Obstruction in Patients Undergoing Liver Transplantation: Prevalence, Predictors, and Association With Cardiovascular EventsBenjamin Cailes, Anoop N Koshy, Paul Gow, et al.
Journal of Gastrointestinal Cancer|September 9, 2020
SIRT Compared with DEB-TACE for Hepatocellular Carcinoma: a Real-world Study (the SITAR Study)Ryan D Hirsch, Chris Mills, Rohit Sawhney, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2019
Retreatment with elbasvir, grazoprevir, sofosbuvir ± ribavirin is effective for GT3 and GT1/4/6 HCV infection after relapseTimothy Papaluca, Marie Sinclair, Paul Gow, et al.
International Journal of Epidemiology|October 16, 2003
Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001Matthew G Law, Gregory J Dore, Nicky Bath, et al.
World Journal of Transplantation|September 19, 2024
Statin, aspirin and metformin use and risk of hepatocellular carcinoma related outcomes following liver transplantation: A retrospective studyWilliam Chung, Kevin Wong, Noel Ravindranayagam, et al.
Science Advances|April 22, 2022
High coherence and low cross-talk in a tileable 3D integrated superconducting circuit architecturePeter A Spring, Shuxiang Cao, Takahiro Tsunoda, et al.
The Lancet. Gastroenterology & Hepatology|December 17, 2022
Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort studyManuel Luis Rodríguez-Perálvarez, Antonio Manuel Gómez-Orellana, Avik Majumdar, et al.
Scandinavian Journal of Gastroenterology|October 19, 2020
Efficacy and safety profile of calcineurin inhibitor salvage therapy in autoimmune hepatitisStuart K Roberts, Simone I Strasser, Amanda J Nicoll, et al.
Scandinavian Journal of Gastroenterology|November 6, 2018
Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survivalStuart K Roberts, Alessia Gazzola, John Lubel, et al.
Pageof 9